Syringes Market Analysis 2021-2031 | Trends and Top Players
The syringes market size in 2021 stood at US$ 15.27 billion and is projected to reach US$ 37.72 billion by 2031. The market is expected to register a CAGR of 9.4% in 2023–2031. Growing inclinations towards prefilled syringe systems and autoinjectors are likely to remain key syringes market trends.
Syringes Market Analysis
The expansion of the healthcare industry, growing incidence of chronic and infectious diseases, increase in vaccination administration rates globally, rising preference for injections due to their faster actions, and growing popularity of disposable syringes are some of the major factors supporting the growth of the syringes market. Syringes are now often utilized in clinical research labs, drug manufacturing, and hospitals. They are being used more and more to deliver a variety of healthcare medications and remove bodily fluids needed for research or disease diagnosis purposes. In addition, the sales of medical syringes are positively impacted by the thriving insulin syringes industry and the growing market penetration of prefilled syringes in emerging nations. Therefore, the growing incidence of infectious and chronic diseases is likely to continue to boost syringe sales during the forecast period.
Syringes Market Overview
A syringe is a piston-like medical instrument that has significant importance in healthcare. Syringes play a major role in the administration of nutritional supplements, vaccines, and medicines. The product has widespread applicability, from injecting of liquid nutritionals into a feeding tube to conducting vaccination. The US healthcare system witnesses massive investments regarding new product introductions. Further, the majority number of players are engaged in business activities such as innovation of products, sales and research partnerships, and product approvals. In addition, cancer is a huge healthcare burden globally. According to the Centers for Disease Control and Prevention, ~1,603,844 new cancer cases were diagnosed in 2020, with 602,347 cancer deaths in the US. For every 100,000 individuals, 403 new cancer cases were reported. Additionally, as per the International Agency for Research on Cancer, new cancer cases were projected to reach 30.2 million by 2040. Syringes are used during numerous stages of cancer treatment, and all these factors are likely to accelerate market growth during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Syringes Market: Strategic Insights
Market Size Value in US$ 12,649.46 Million in 2019 Market Size Value by US$ 26,859.34 Million by 2027 Growth rate CAGR of 9.8% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Syringes Market: Strategic Insights
| Market Size Value in | US$ 12,649.46 Million in 2019 |
| Market Size Value by | US$ 26,859.34 Million by 2027 |
| Growth rate | CAGR of 9.8% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Syringes Market Drivers and Opportunities
Increasing Number of Chronic and Infectious Diseases to Drive the Market Growth
Chronic diseases including cardiovascular disease, diabetes, and cancer, are among the major causes of death in adults. Infectious diseases are also the top causes of death in children and adults. Globally, about one in three of all adults suffer from multiple chronic conditions. In the US, six in ten adults have a chronic disease, and four in ten adults have two or more. Chronic and infectious diseases require continuous diagnosis using various medical tests requiring the use of syringes. The growing aging population and changes in social behavior and lifestyle contribute to some of the common long-term health conditions. As per the World Health Organization, the prevalence of chronic lifestyle diseases is expected to increase by 57% by the end of 2026. Diabetes is one of the major worldwide health issues of the 21st century. According to the International Diabetes Federation, ~537 million people were living with diabetes in 2021, and the number is anticipated to reach 738 million by 2045 globally. According to a report by the Centers for Disease Control and Prevention, over 37 million Americans (~1 in 10) have diabetes, and nearly 90–95% of them have type 2 diabetes. The growing adoption of injectable drugs for the treatment of chronic and infectious diseases is anticipated to drive the demand and adoption of syringes, thereby driving market growth.
Product Launches by Market Players to Favor Market Growth
Various market players focus on product launches or strategic collaborations for the development of advanced products that help in the treatment of chronic disorders with ease. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years. A few of them are mentioned below:
In October 2022, Terumo Pharmaceutical Solutions, a division of Terumo Corporation, launched a ready-to-fill polymer syringe for challenging biotech drugs with larger volumes. The PLAJEX 2.25 mL with Tapered Needle is particularly designed to meet the biotechnology market, making it appropriate for complex drug applications, such as high-viscosity biotech medications.
In September 2022, Becton, Dickinson and Company introduced a next-generation glass prefillable syringe that establishes a new standard in performance for vaccine prefillable syringes with new and tightened specifications. The new BD effivax glass prefillable syringe has been designed in collaboration with prominent pharmaceutical companies to meet the complex and progressing needs of vaccine manufacturing.
Thus, a surge in product launches is likely to create considerable growth opportunities for the syringes market in the future.
Syringes Market Report Segmentation Analysis
Key segments that contributed to the derivation of the syringes market analysis are ingredient type, form, and indication.
- Based on syringe type, the syringes market is divided into Luer lock syringes, glass syringes, Luer slip syringes, others. The Luer lock syringes segment held the largest market share in 2023. In addition, the glass syringes segment is anticipated to register the highest CAGR during the forecast period.
- By application, the market is segmented into aesthetics, human health, lab/industrial applications, other applications. The human health segment held the largest share of the market in 2023. In addition, the aesthetics segment is projected to register the highest CAGR during the forecast period.
- In terms of usability, the market is categorized into sterilizable/reusable syringes, disposable syringes. The disposable syringes segment held the largest market share in 2023 and is anticipated to register the highest CAGR during the forecast period.
- Based on end user, the syringes market is divided into hospital and clinics, blood collection centres, diabetic care centres, other end user. The hospital and clinics segment held the largest market share in 2023. In addition, the diabetic care centres segment is anticipated to register the highest CAGR during the forecast period.
Syringes Market Share Analysis by Geography
The geographic scope of the syringes market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the syringes market. North America market is expanding due to a number of factors, including the rising prevalence of chronic and lifestyle illnesses, an increase in product approvals, rising awareness regarding specialized syringes, rising advancements in injectable devices, and an increase in approvals for biologics. West Pharmaceutical Services, Inc., a company that produces innovative solutions for injectable drug administration, revealed its new pre-fillable Daikyo Crystal Zenith 2.25mL Insert Needle Syringe System at the BIO International Convention in June 2022. Daikyo Crystal Zenith is a technologically advanced cyclic olefin polymer containment and delivery system that offers a replacement for glass, reducing the risk of breakage and mitigating the chance of particulates, contamination, and extractable.
Asia Pacific is anticipated to grow with the highest CAGR in the coming years. Growing technological advancements, a rapidly aging population, increasing focus from international players on the region, fast urbanization, and supportive regulatory frameworks for the approval of novel injectables are supporting the growth of the market in the region.
Syringes Market Report Scope
Syringes Market News and Recent Developments
The syringes market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for syringes and strategies:
- In November 2023, Terumo India, the Indian arm of Terumo Corporation, launched Insulin Syringe, a sterile delivery device for patients requiring regular insulin injections, thereby raising the bar for patient comfort and therapy compliance. These syringes, along with the company’s Pen needles - FineGlide, are also available as standalone products in all major pharmacies across India. (Source: Terumo Corporation, Press Release, 2023)
- In January 2022, ICU Medical Inc. completed the acquisition of Smiths Medical from Smiths Group plc. The addition of Smiths Medical’s business, including syringe and ambulatory infusion devices, vascular access, and vital care products, to the ICU Medical portfolio creates a leading infusion therapy company with a more robust global reach. (Source: ICU Medical, Press Release, 2022)
Syringes Market Report Coverage and Deliverables
The “Syringes Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Syringe Type , Application , Usability , and End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, Egypt, France, Germany, India, Italy, Japan, Mexico, Morocco, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, Turkey, United Arab Emirates, United Kingdom, United States
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For